报告题目：Designing & developing next generation medical technologies: A convergence between biomedical engineering and pharmaceutical science
报 告 人：Prof. Sally-Ann Cryan（School of Pharmacy，Royal College of Surgeons in Ireland）
报告时间：2014年5月16日（星期五）下午2:00
报告地点：独墅湖校区二期云轩楼2301室
Prof. Sally-Ann Cryan简介
Sally-Ann Cryan graduated with a BSc. (Pharmacy) from Trinity College, Dublin (TCD), subsequently carried out PhD research in pharmaceutical biotechnology in TCD and went on to work as a Post-doctoral Research Fellow in RCSI. In 2003, she was awarded a Fulbright Scholarship to carry out research the Schools of Pharmacy and Medicine, University of North Carolina at Chapel Hill. In 2004 she was appointed as Lecturer in Pharmaceutics in the School of Pharmacy, Senior Lecturer in October 2008 and promoted to Associate Professor in Pharmaceutics in 2013. She is a founding member and PI of the SFI-funded Irish Drug Delivery Network (IDDN) (http://www.ucd.ie/iddn/), a PI in the RCSI Tissue Engineering Research Group (TERG) and was recently appointed as a PI in the Trinity Centre for Bioengineering. Her research group collaborates extensively with clinical, industrial & biomedical research groups and is currently part of two EU FP7 consortia AMCARE (www.amcare.eu) (Co-ordinator:Dr. G Duffy) and NeoGel (http://www.accelopment.com/en/projects/neogel) (Co-ordinator Dr. A Heise, DCU). for Bioengineering.
